1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pediatric HIV Infection Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Not Symptomatic 1.2.3 Mildly Symptomatic 1.2.4 Moderately Symptomatic 1.2.5 Severely Symptomatic 1.3 Market by Application 1.3.1 Global Pediatric HIV Infection Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.3.5 Drugstore 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pediatric HIV Infection Treatment Market Perspective (2017-2028) 2.2 Pediatric HIV Infection Treatment Growth Trends by Region 2.2.1 Pediatric HIV Infection Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Pediatric HIV Infection Treatment Historic Market Size by Region (2017-2022) 2.2.3 Pediatric HIV Infection Treatment Forecasted Market Size by Region (2023-2028) 2.3 Pediatric HIV Infection Treatment Market Dynamics 2.3.1 Pediatric HIV Infection Treatment Industry Trends 2.3.2 Pediatric HIV Infection Treatment Market Drivers 2.3.3 Pediatric HIV Infection Treatment Market Challenges 2.3.4 Pediatric HIV Infection Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pediatric HIV Infection Treatment Players by Revenue 3.1.1 Global Top Pediatric HIV Infection Treatment Players by Revenue (2017-2022) 3.1.2 Global Pediatric HIV Infection Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Pediatric HIV Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Pediatric HIV Infection Treatment Revenue 3.4 Global Pediatric HIV Infection Treatment Market Concentration Ratio 3.4.1 Global Pediatric HIV Infection Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pediatric HIV Infection Treatment Revenue in 2021 3.5 Pediatric HIV Infection Treatment Key Players Head office and Area Served 3.6 Key Players Pediatric HIV Infection Treatment Product Solution and Service 3.7 Date of Enter into Pediatric HIV Infection Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pediatric HIV Infection Treatment Breakdown Data by Type 4.1 Global Pediatric HIV Infection Treatment Historic Market Size by Type (2017-2022) 4.2 Global Pediatric HIV Infection Treatment Forecasted Market Size by Type (2023-2028) 5 Pediatric HIV Infection Treatment Breakdown Data by Application 5.1 Global Pediatric HIV Infection Treatment Historic Market Size by Application (2017-2022) 5.2 Global Pediatric HIV Infection Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Pediatric HIV Infection Treatment Market Size (2017-2028) 6.2 North America Pediatric HIV Infection Treatment Market Size by Country (2017-2022) 6.3 North America Pediatric HIV Infection Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Pediatric HIV Infection Treatment Market Size (2017-2028) 7.2 Europe Pediatric HIV Infection Treatment Market Size by Country (2017-2022) 7.3 Europe Pediatric HIV Infection Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Pediatric HIV Infection Treatment Market Size (2017-2028) 8.2 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Pediatric HIV Infection Treatment Market Size (2017-2028) 9.2 Latin America Pediatric HIV Infection Treatment Market Size by Country (2017-2022) 9.3 Latin America Pediatric HIV Infection Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pediatric HIV Infection Treatment Market Size (2017-2028) 10.2 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Detail 11.1.2 GSK Business Overview 11.1.3 GSK Pediatric HIV Infection Treatment Introduction 11.1.4 GSK Revenue in Pediatric HIV Infection Treatment Business (2017-2022) 11.1.5 GSK Recent Development 11.2 F.Hoffmann-La Roche 11.2.1 F.Hoffmann-La Roche Company Detail 11.2.2 F.Hoffmann-La Roche Business Overview 11.2.3 F.Hoffmann-La Roche Pediatric HIV Infection Treatment Introduction 11.2.4 F.Hoffmann-La Roche Revenue in Pediatric HIV Infection Treatment Business (2017-2022) 11.2.5 F.Hoffmann-La Roche Recent Development 11.3 Johnson & Johnson Services 11.3.1 Johnson & Johnson Services Company Detail 11.3.2 Johnson & Johnson Services Business Overview 11.3.3 Johnson & Johnson Services Pediatric HIV Infection Treatment Introduction 11.3.4 Johnson & Johnson Services Revenue in Pediatric HIV Infection Treatment Business (2017-2022) 11.3.5 Johnson & Johnson Services Recent Development 11.4 ViiV Healthcare 11.4.1 ViiV Healthcare Company Detail 11.4.2 ViiV Healthcare Business Overview 11.4.3 ViiV Healthcare Pediatric HIV Infection Treatment Introduction 11.4.4 ViiV Healthcare Revenue in Pediatric HIV Infection Treatment Business (2017-2022) 11.4.5 ViiV Healthcare Recent Development 11.5 Apotex 11.5.1 Apotex Company Detail 11.5.2 Apotex Business Overview 11.5.3 Apotex Pediatric HIV Infection Treatment Introduction 11.5.4 Apotex Revenue in Pediatric HIV Infection Treatment Business (2017-2022) 11.5.5 Apotex Recent Development 11.6 Camber Pharmaceuticals 11.6.1 Camber Pharmaceuticals Company Detail 11.6.2 Camber Pharmaceuticals Business Overview 11.6.3 Camber Pharmaceuticals Pediatric HIV Infection Treatment Introduction 11.6.4 Camber Pharmaceuticals Revenue in Pediatric HIV Infection Treatment Business (2017-2022) 11.6.5 Camber Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pediatric HIV Infection Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Not Symptomatic Table 3. Key Players of Mildly Symptomatic Table 4. Key Players of Moderately Symptomatic Table 5. Key Players of Severely Symptomatic Table 6. Global Pediatric HIV Infection Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Pediatric HIV Infection Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Pediatric HIV Infection Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Pediatric HIV Infection Treatment Market Share by Region (2017-2022) Table 10. Global Pediatric HIV Infection Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Pediatric HIV Infection Treatment Market Share by Region (2023-2028) Table 12. Pediatric HIV Infection Treatment Market Trends Table 13. Pediatric HIV Infection Treatment Market Drivers Table 14. Pediatric HIV Infection Treatment Market Challenges Table 15. Pediatric HIV Infection Treatment Market Restraints Table 16. Global Pediatric HIV Infection Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Pediatric HIV Infection Treatment Market Share by Players (2017-2022) Table 18. Global Top Pediatric HIV Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric HIV Infection Treatment as of 2021) Table 19. Ranking of Global Top Pediatric HIV Infection Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Pediatric HIV Infection Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pediatric HIV Infection Treatment Product Solution and Service Table 23. Date of Enter into Pediatric HIV Infection Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pediatric HIV Infection Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Pediatric HIV Infection Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Pediatric HIV Infection Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Pediatric HIV Infection Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Pediatric HIV Infection Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Pediatric HIV Infection Treatment Revenue Market Share by Application (2017-2022) Table 31. Global Pediatric HIV Infection Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Pediatric HIV Infection Treatment Revenue Market Share by Application (2023-2028) Table 33. North America Pediatric HIV Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Pediatric HIV Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Pediatric HIV Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Pediatric HIV Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Pediatric HIV Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Pediatric HIV Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. GSK Company Detail Table 44. GSK Business Overview Table 45. GSK Pediatric HIV Infection Treatment Product Table 46. GSK Revenue in Pediatric HIV Infection Treatment Business (2017-2022) & (US$ Million) Table 47. GSK Recent Development Table 48. F.Hoffmann-La Roche Company Detail Table 49. F.Hoffmann-La Roche Business Overview Table 50. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Product Table 51. F.Hoffmann-La Roche Revenue in Pediatric HIV Infection Treatment Business (2017-2022) & (US$ Million) Table 52. F.Hoffmann-La Roche Recent Development Table 53. Johnson & Johnson Services Company Detail Table 54. Johnson & Johnson Services Business Overview Table 55. Johnson & Johnson Services Pediatric HIV Infection Treatment Product Table 56. Johnson & Johnson Services Revenue in Pediatric HIV Infection Treatment Business (2017-2022) & (US$ Million) Table 57. Johnson & Johnson Services Recent Development Table 58. ViiV Healthcare Company Detail Table 59. ViiV Healthcare Business Overview Table 60. ViiV Healthcare Pediatric HIV Infection Treatment Product Table 61. ViiV Healthcare Revenue in Pediatric HIV Infection Treatment Business (2017-2022) & (US$ Million) Table 62. ViiV Healthcare Recent Development Table 63. Apotex Company Detail Table 64. Apotex Business Overview Table 65. Apotex Pediatric HIV Infection Treatment Product Table 66. Apotex Revenue in Pediatric HIV Infection Treatment Business (2017-2022) & (US$ Million) Table 67. Apotex Recent Development Table 68. Camber Pharmaceuticals Company Detail Table 69. Camber Pharmaceuticals Business Overview Table 70. Camber Pharmaceuticals Pediatric HIV Infection Treatment Product Table 71. Camber Pharmaceuticals Revenue in Pediatric HIV Infection Treatment Business (2017-2022) & (US$ Million) Table 72. Camber Pharmaceuticals Recent Development Table 73. Research Programs/Design for This Report Table 74. Key Data Information from Secondary Sources Table 75. Key Data Information from Primary Sources List of Figures Figure 1. Global Pediatric HIV Infection Treatment Market Share by Type: 2021 VS 2028 Figure 2. Not Symptomatic Features Figure 3. Mildly Symptomatic Features Figure 4. Moderately Symptomatic Features Figure 5. Severely Symptomatic Features Figure 6. Global Pediatric HIV Infection Treatment Market Share by Application in 2021 & 2028 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Drugstore Case Studies Figure 11. Others Case Studies Figure 12. Pediatric HIV Infection Treatment Report Years Considered Figure 13. Global Pediatric HIV Infection Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Pediatric HIV Infection Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Pediatric HIV Infection Treatment Market Share by Region: 2021 VS 2028 Figure 16. Global Pediatric HIV Infection Treatment Market Share by Players in 2021 Figure 17. Global Top Pediatric HIV Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric HIV Infection Treatment as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Pediatric HIV Infection Treatment Revenue in 2021 Figure 19. North America Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America Pediatric HIV Infection Treatment Market Share by Country (2017-2028) Figure 21. United States Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Pediatric HIV Infection Treatment Market Share by Country (2017-2028) Figure 25. Germany Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Pediatric HIV Infection Treatment Market Share by Region (2017-2028) Figure 33. China Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Pediatric HIV Infection Treatment Market Share by Country (2017-2028) Figure 41. Mexico Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Pediatric HIV Infection Treatment Market Share by Country (2017-2028) Figure 45. Turkey Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia Pediatric HIV Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. GSK Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2017-2022) Figure 48. F.Hoffmann-La Roche Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2017-2022) Figure 49. Johnson & Johnson Services Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2017-2022) Figure 50. ViiV Healthcare Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2017-2022) Figure 51. Apotex Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2017-2022) Figure 52. Camber Pharmaceuticals Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

GSK F.Hoffmann-La Roche Johnson & Johnson Services ViiV Healthcare Apotex Camber Pharmaceuticals